Column

Editor's Page

A Look Into the Future: What`s Next for Pathways?

03/15/2017

Health care delivery is always in flux, but treatment advances over the last several years have introduced new variables into the health care continuum that were unthinkable even a decade ago. Researchers, providers,...

Health...

03/15/2017

Journal of Clinical Pathways

Counterpoint

In the Next Generation of Value-Based Contracting, Clinical Pathways Can Increase Accountability

02/13/2017

Karen K. Fields , MD;

Cynthia Terrano , CPA;

The shift from fee-for-service to value-based payment systems is likely to continue, and clinical pathways afford the opportunity to incorporate detailed cost information and embed quality endpoints into the...

The...

02/13/2017

Journal of Clinical Pathways

Viewpoint

Post-Election Pathways Will Focus on Patients` Definition of Value

02/13/2017

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Scott Guerin , PhD;

As the Republican party gains control over federal health care policy, it seems likely that patients will have much more involvement in their health care in terms of decision-making capacity and out-of-pocket...

As the...

02/13/2017

Journal of Clinical Pathways

Pharma Insights

How Health System and Payer Perception of Value May Determine the Promise of Gene Therapies

02/13/2017

Larry Blandford , PharmD;

Auralyn MacKenzie , BSc;

The launch of gene therapies is imminent. Much of the discussion has centered on the possible prices of these treatments rather than on their value and management. The value of different gene therapies is likely to...

The...

02/13/2017

Journal of Clinical Pathways

Editor's Page

Making Pathways and Care More Consumer-Focused

02/13/2017

Winston Wong , PharmD;

Amid the recent political changes in the United States, there has been plentiful discussion about what the future of health care will look like. Certain policies brought about as a result of the Patient...

...

02/13/2017

Journal of Clinical Pathways

Counterpoint

Deliver Care, But Also Engage the Patient

12/13/2016

Winston Wong , PharmD;

This article was written in response to the Viewpoint: "Rethinking Health Care Delivery."   As patients’ financial responsibility for their care increases, the burden of this patient responsibility is becoming...

This...

12/13/2016

Journal of Clinical Pathways

Viewpoint

Rethinking Health Care Delivery

12/13/2016

Ned L. Woody ;

The unidirectional manner in which patients often “receive,” and providers often “deliver,” health care results in a system in which patients are not adequately involved in decision-making processes affecting their...

The...

12/13/2016

Journal of Clinical Pathways

Clinical Pathways GPS

Going Beyond Multiple Sclerosis Treatments to Address Problematic Symptoms

12/13/2016

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Nader Tavakoli , MD, CMD, FAAFP;

Aysha Khan , MD;

Multiple sclerosis (MS) is a disabling condition that is managed medically through an ever growing list of pharmaceutical treatments. Clinical pathways that focus primarily on treatments for the disease overlook...

...

12/13/2016

Journal of Clinical Pathways

Pharma Insights

"Care Creativity" Innovations Transform Medicare Advantage Five-Star Plans

12/13/2016

Larry Blandford , PharmD;

Maureen Hennessey , PhD, CPCC, CPHQ;

The Affordable Care Act of 2010 has transformed the health care landscape by providing strong incentives to insurers to improve the overall quality of care through the Five-Star Quality Rating System. The success of...

The...

12/13/2016

Journal of Clinical Pathways

Editor's Page

Where Do Clinical Pathways Go From Here?

12/12/2016

Winston Wong , PharmD;

As we bring a close to 2016, the first full year of publication of Journal of Clinical Pathways (JCP), it is a good opportunity to reflect on how the role of clinical pathways in the health care landscape has grown...

As we...

12/12/2016

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Column

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products